(Reuters) – The U.S. Food and Drug Administration said on Friday it shortened the stipulated time between the primary series of the Moderna COVID-19 vaccine and a booster dose by a month to at least five months for people aged 18 or above.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)
